FEPAMIC CÓRDOBA EXOSKELETON | The Fepamic Foundation will present its pediatric exoskeleton on June 28 in Córdoba

FEPAMIC CÓRDOBA EXOSKELETON | The Fepamic Foundation will present its pediatric exoskeleton on June 28 in Córdoba
FEPAMIC CÓRDOBA EXOSKELETON | The Fepamic Foundation will present its pediatric exoskeleton on June 28 in Córdoba

The foundation Fepamic plans to present at the second meeting of the Network of Highly Committed Companies (REAC), whose celebration is scheduled for On June 28, the children’s exoskeleton for therapeutic purposes that you have acquired to use it for treatment and rehabilitation for children with serious pathologies of the neuromusculoskeletal system or with cerebral palsy.

The director of the Fepamic Foundation, Alfonso Ariza, points out that the cost to incorporate this technology is quite high, about 270,000 euros.having paid for this technology with the contributions made by the Fepamic Foundation itself (with the support of different entities and with a loan that has been requested), the highly committed companies that are part of REACas well as with aid received by the Solidarity Foundation Carrefour, Cajasur Foundation, Provincial Council of Córdoba and Roviralta Foundation.

Beneficiaries of the exoskeleton

According to Arizathe beneficiaries will be minors with great support needs and that they will see their level of autonomy and well-being improved thanks to the implementation of this novel robotic technology in the rehabilitation unit of the Fepamic Foundation.

The exoskeleton purchased by the Fepamic Foundation is an 8-degree-of-freedom active robotic orthosis, a dExternal device applied to the human body to modify the functional or structural aspects of the neuromusculoskeletal system. Its higher price, compared to other exoskeleton models, is due to the fact that it can be used by different people, not just one.

Alfonso Ariza specifies that this technology constitutes the only mobile pediatric exoskeleton on the market and highlights that it aims to improve the user’s motor level, hoping to increase life expectancy and reduce or delay the complications of the pathology that the patient suffers, among which are neuromuscular diseases (spinal muscular atrophy, muscular dystrophies, myopathies, among others). others), or cerebral palsy.

#Colombia

 
For Latest Updates Follow us on Google News
 

-